The cyclic nucleotide phosphodiesterase 4 (PDE4) regulates the hydrolysis of the second messenger cyclic AMP. cAMP is a major intracellular signalling mediator that directly affects the activity ...

Activation of AMP-activated kinase (AMPK) is a potential therapeutic target to treat metabolic diseases. Its activation shifts metabolism so that glucose and fatty acids from the diet are used to ...

The results, published in JCI Insight on April 22, 2025, suggest that the drug apremilast-a phosphodiesterase-4 (PDE4) inhibitor, or a compound that blocks an enzyme involved in inflammation-could ...

Announcing a new publication for Acta Materia Medica journal. Phosphodiesterase-4 (PDE4), a member of the phosphodiesterase superfamily, has highly important roles in cyclic nucleotide signaling ...